Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme

Human Reproduction

Volumn 12, Issue 12, 1997, Pages 2599-2602

  Graf, Michael A ^a   Fischer, Robert ^a   Naether, Olaf G J ^a   Baukloh, Vera ^a   Tafel, Jörg ^a   Nückel, Michael ^a  

^a IVF Unit   (Germany)

Author keywords

Human serum albumin infusion; Hydroxyaethyl starch infusion; In vitro fertilization; Ovarian hyperstimulation syndrome; Prophylactic therapy

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; HETASTARCH; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OVARY DISEASE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRURITUS; RETROSPECTIVE STUDY; SKIN MANIFESTATION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; URTICARIA;

EID: 0031449530     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/12.12.2599     Document Type: Article

References (25)

1. Abramov, Y., Barak, V., Nisman, B. et al. (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril., 67, 261-265.
2. Asch, R.H., Li, H.P., Balmaceda, J.P. et al. (1991) Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum. Reprod., 6, 1395-1399.
3. Asch, R.H., Ivery, G., Goldsman, M. et al. (1993) The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1015-1020.
4. Asch, R.H. (1994) Letter to the Editor: Does intravenous albumin prevent ovarian hyperstimulation syndrome? Hum. Reprod., 9, 753-754.
5. Delbaere, A., Bergmann, P.J.M., Gervy-Decoster, C. et al. (1997) Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum. Reprod., 12, 236-240.
6. Hignett, M., Spence, J.E.H. and Claman, P. (1995) Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hum. Reprod., 10, 3121-3123.
7. Lewit, N., Kol, S., Ronen, N. et al. (1996a) Does intravenous administration of human albumin prevent severe ovarian hyperstimulation syndrome? Fertil. Steril., 66, 654-656.
8. Lewit, N., Kol, S., Manor, D. et al. (1996b) Comparison of gonadotrophin releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study. Hum. Reprod., 11, 1399-1402,
9. Mills, M.S., Eddowes H.A., Fox, R. et al. (1992) Subclavian vein thrombosis: a late complication of ovarian hyperstimulation syndrome. Hum. Reprod., 7, 370-371.
10. Morris, R.S. and Paulson, R.J. (1994) Letter to the Editor: Does intravenous albumin prevent ovarian hyperstimulation syndrome? Hum. Reprod., 9, 753.
11. Mukherjee, T., Copperman, A.B., Sandler, B. et al. (1995) Severe ovarian hyperstimulation despite prophylactic albumin administration at the time of oocyte retrieval for in vitro fertilization and embryo transfer. Fertil. Steril., 64, 641-643.
12. Navot, D., Bergh, P.A. and Laufer, N. (1992) Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 58, 249-261.
13. Neulen, J., Yan, Z., Raczek, S. et al. (1995) Ovarian hyperstimulation syndrome: vascular endothelial growth factor/vascular permeability factor from luteinized granulosa cells is the pathophysiological principle. Hum. Reprod., 10 (Abstr. Bk. 2) p.3.
14. Ng, E., Leader, A., Claman, P. et al. (1995) Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme. Hum. Reprod., 10, 807-810.
15. Orvieto, R., Voliovitch, I., Fishman, P. et al. (1995a) Interleukin-2 and ovarian hyperstimulation syndrome - a pilot study. Hum. Reprod., 10, 24-27.
16. Orvieto, R., Dekel, A., Dicker, D. et al. (1995b) A severe case of ovarian hyperstimulation syndrome despite the prophylactic administration of intravenous albumin. Fertil. Steril, 64, 860-862.
17. Rabau, E., David, A., Serr, D.M. et al. (1967) Human menopausal gonadotropins for anovulation and sterility. Am. J. Obstet. Gynecol., 96, 92-98.
18. Ring, J. and Messmer, K. (1977) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet, 1, 466-469.
19. Schenker, J.G. and Polishuk, W.Z. (1976) Role of prostaglandins in ovarian hyperstimulation syndrome. Obstet. Gynecol. Surv., 31, 742-745.
20. Schenker, J.G. and Weinstein, D. (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil. Steril., 30, 255-268.
21. Shaker, A.G., Zosmer, A., Dean, N. et al. (1996) Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil. Steril. 60, 992-996.
22. Shalev, E., Giladi, Y., Matilsky, M. et al. (1995) Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study. Hum. Reprod., 10, 1373-1376.
23. Sher, G., Zouves, C., Feinman, M. et al. (1995) 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum. Reprod., 10, 3107-3109.
24. Shoham, Z., Weissman, A., Barash, A. et al. (1994) Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study. Fertil. Steril, 62, 137-142.
25. Zosmer, A., Katz, Z., Lancet, M. et al. (1987) Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome. Fertil. Steril., 47, 524-526.